Imran Hamid,

Senior Director of New Ventures and Transactions

Dr Imran Hamid is Senior Director of New Ventures and Transactions for Johnson & Johnson Innovation. Imran leads the identification and sourcing of early stage transformative innovation, and the subsequent shaping and execution of transactions opportunities across Johnson & Johnson Medical Devices Companies.

Imran is a former Trauma & Orthopaedic surgeon, digital health entrepreneur and has served as a strategic advisor to several pharmaceutical, medical device and private equity companies. Prior to joining Johnson & Johnson, Imran was Director of Business Development & Licensing at Mallinckrodt and Director of Commercial Discovery at Merck & Co.

Imran has a broad range of deal experience including start-up and corporate fundraising, licensing, and M&A transactions, spanning pre-revenue, growth stage and mature assets.

Imran received his medical degree from Imperial College London, where he graduated with joint honours from the Imperial College Business School and is a member of the Royal College of Surgeons. Imran is committed to using his experiences to advance surgical innovation, improve clinical outcomes and deliver higher quality care for patients.


Imran Hamid
Imran Hamid